Glaxo AIDS Drug Has 'Spectacular' Results in Study

Courtesy Newsvine - business  Wed, 07/22/2009 - 07:14

GlaxoSmithKline Plc's experimental AIDS drug reduced the virus as much as 500-fold without the signs of resistance linked to treatments from Merck & Co. and Gilead Sciences Inc., a study showed.


 

Related items

Notable 52-Week Highs and Lows of the Day 02/06:...
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High:Threshold Pharmaceuticals (Nasdaq: THLD) high of $4.08....

Notable 52-Week Highs and Lows of the Day 02/03:...
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High:Gilead Sciences, Inc. (Nasdaq: GILD) high of $54.77. Gilead...

Notable 52-Week Highs and Lows of the Day 01/10:...
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High:Gilead Sciences Inc. (Nasdaq: GILD) high of $45.04. Could be...

Samsung SCX-4200 3-in-1 True Multifunction Printer
The SCX-4200 Digital Productivity Center is a low cost black and white laser printer, delivering 3 in 1 true multifunction performance with professional laser output.Keep your valuable real...

BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
The X5 Stereo Bluetooth Headset is a portable multi-function device utilizing the latest cutting edge technologies allowing you to stream high quality music and make voice calls using a...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com